163 related articles for article (PubMed ID: 28346771)
1. Cohort study of oncologic emergencies in patients with head and neck cancer.
Reyes-Gibby CC; Melkonian SC; Hanna EY; Yeung SJ; Lu C; Chambers MS; Banala SR; Gunn GB; Shete SS
Head Neck; 2017 Jun; 39(6):1195-1204. PubMed ID: 28346771
[TBL] [Abstract][Full Text] [Related]
2. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and prognosis in patients with head and neck cancer.
Gama RR; Song Y; Zhang Q; Brown MC; Wang J; Habbous S; Tong L; Huang SH; O'Sullivan B; Waldron J; Xu W; Goldstein D; Liu G
Head Neck; 2017 Jun; 39(6):1226-1233. PubMed ID: 28323362
[TBL] [Abstract][Full Text] [Related]
4. Emergency presentations of head and neck cancer: a modern perspective.
Bannister M; Vallamkondu V; Ah-See KW
J Laryngol Otol; 2016 Jun; 130(6):571-4. PubMed ID: 27112730
[TBL] [Abstract][Full Text] [Related]
5. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Kwon M; Kim RB; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Head Neck; 2017 Apr; 39(4):716-723. PubMed ID: 28000343
[TBL] [Abstract][Full Text] [Related]
7. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
[TBL] [Abstract][Full Text] [Related]
8. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
9. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
Kligerman MP; Sethi RKV; Kozin ED; Gray ST; Shrime MG
Head Neck; 2019 Apr; 41(4):1007-1015. PubMed ID: 30676682
[TBL] [Abstract][Full Text] [Related]
11. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
[TBL] [Abstract][Full Text] [Related]
12. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
13. Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.
Eskander A; Krzyzanowska MK; Fischer HD; Liu N; Austin PC; Irish JC; Enepekides DJ; Lee J; Gutierrez E; Lockhart E; Raphael M; Singh S
Oral Oncol; 2018 Aug; 83():107-114. PubMed ID: 30098764
[TBL] [Abstract][Full Text] [Related]
14. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
[TBL] [Abstract][Full Text] [Related]
15. Distant metastases in head and neck cancer.
Duprez F; Berwouts D; De Neve W; Bonte K; Boterberg T; Deron P; Huvenne W; Rottey S; Mareel M
Head Neck; 2017 Sep; 39(9):1733-1743. PubMed ID: 28650113
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
[TBL] [Abstract][Full Text] [Related]
17. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
Araki D; Redman MW; Martins R; Eaton K; Baik C; Chow L; Goulart B; Lee S; Santana-Davila R; Liao J; Parvathaneni U; Laramore G; Futran N; Mendez E; Bhrany A; Rodriguez CP
Head Neck; 2016 Sep; 38(9):1318-23. PubMed ID: 27061333
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.
Singh B; Bhaya M; Zimbler M; Stern J; Roland JT; Rosenfeld RM; Har-El G; Lucente FE
Head Neck; 1998 Jan; 20(1):1-7. PubMed ID: 9464945
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]